title: A placebo-controlled double-blind study of epalrestat (ONO-2235) in patients with diabetic neuropathy.
authors.affiliation: Department of Internal Medicine, Tohoku Kosei-Nenkin Hospital, Japan.
authors.forename: Y
authors.initials: Y
authors.lastname: Goto
authors.forename: N
authors.initials: N
authors.lastname: Hotta
authors.forename: Y
authors.initials: Y
authors.lastname: Shigeta
authors.forename: N
authors.initials: N
authors.lastname: Sakamoto
authors.forename: S
authors.initials: S
authors.lastname: Kito
authors.forename: K
authors.initials: K
authors.lastname: Matsuoka
authors.forename: A
authors.initials: A
authors.lastname: Takahashi
authors.forename: R
authors.initials: R
authors.lastname: Kikkawa
authors.forename: A
authors.initials: A
authors.lastname: Sakuma
mesh_terms: D000328:Adult; D000449:Aldehyde Reductase / Q000037:antagonists & inhibitors*; D003929:Diabetic Neuropathies / Q000097:blood / Q000188:drug therapy* / Q000503:physiopathology; D004311:Double-Blind Method; D006442:Glycated Hemoglobin / Q000032:analysis; D006801:Humans; D008475:Median Nerve / Q000187:drug effects / Q000503:physiopathology; D008875:Middle Aged; D009431:Neural Conduction / Q000187:drug effects; D010543:Peroneal Nerve / Q000187:drug effects / Q000503:physiopathology; D010919:Placebos; D012236:Rhodanine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D053778:Thiazolidines
chemical_list: D000449:Aldehyde Reductase; D006442:Glycated Hemoglobin; D010919:Placebos; D012236:Rhodanine; D053778:Thiazolidines; C038131:epalrestat